Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B0ZQ
|
||||
Former ID |
DNC008154
|
||||
Drug Name |
RB 2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529152] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H17ClN7Na3O11S3
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC<br />5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)[O-])Cl)S(=O)(=O)[O<br />-])S(=O)(=O)[O-])N.[Na+].[Na+].[Na+]
|
||||
InChI |
1S/C29H20ClN7O11S3.3Na/c30-27-35-28(33-13-4-3-5-15(10-13)49(40,41)42)37-29(36-27)34-18-9-8-14(11-20(18)50(43,44)45)32-19-12-21(51(46,47)48)24(31)23-22(19)25(38)16-6-1-2-7-17(16)26(23)39;;;/h1-12,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H2,33,34,35,36,37);;;/q;3*+1/p-3
|
||||
InChIKey |
VZPXDCIISFTYOM-UHFFFAOYSA-K
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | P2Y purinoceptor 6 | Target Info | Inhibitor | [530711] | |
5'-Nucleotidase | Target Info | Inhibitor | [530711] | ||
P2Y purinoceptor 2 | Target Info | Inhibitor | [529152] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
PANTHER Pathway | Purine metabolism | ||||
Pyrimidine Metabolism | |||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
WikiPathways | Nucleotide GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP2848:Differentiation Pathway | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
Metabolism of nucleotidesWP80:Nucleotide GPCRs | |||||
GPCR downstream signaling | |||||
References | |||||
Ref 529152 | Bioorg Med Chem Lett. 2008 Jan 1;18(1):223-7. Epub 2007 Oct 30.Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists. | ||||
Ref 530711 | J Med Chem. 2010 Mar 11;53(5):2076-86.Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.